Evidence map›Paper›PMID 25425581›Full record

ArticleJournal of dental research2015

Cantharidins induce ER stress and a terminal unfolded protein response in OSCC.

Y Xi, D M Garshott, A L Brownell, G H Yoo, H-S Lin, T L Freeburg, N G Yoo, R J Kaufman, M U Callaghan, A M Fribley

Open access · greenAbstract read
In one paragraph

Article in Journal of dental research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Overexpression of CHOP in Myelinating Cells Does Not Confer a Significant Phenotype under Normal or Metabolic Stress Conditions.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Y XiThe Key Laboratory of Pathiobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, China Carmen and Ann Adams Department of Pediatrics, Division of Hematology Oncology, Children's Hospital of Michigan, Detroit, MI, USA.
D M GarshottCarmen and Ann Adams Department of Pediatrics, Division of Hematology Oncology, Children's Hospital of Michigan, Detroit, MI, USA.
A L BrownellCarmen and Ann Adams Department of Pediatrics, Division of Hematology Oncology, Children's Hospital of Michigan, Detroit, MI, USA.
G H YooDepartment of Otolaryngology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA.
H-S LinDepartment of Otolaryngology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA.
T L FreeburgDepartment of Otolaryngology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA.
N G YooDepartment of Otolaryngology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA.
R J KaufmanDegenerative Diseases Program, Sanford|Burnham Medical Research Institute, La Jolla, CA and Department of Pharmacology, University of California Medical Center, La Jolla, CA, USA.
M U CallaghanCarmen and Ann Adams Department of Pediatrics, Division of Hematology Oncology, Children's Hospital of Michigan, Detroit, MI, USA.
A M FribleyCarmen and Ann Adams Department of Pediatrics, Division of Hematology Oncology, Children's Hospital of Michigan, Detroit, MI, USA Department of Otolaryngology, Wayne State University and Karmanos Cancer Institute, Detroit, MI, USA Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA rkaufman@sanfordburnham.org afribley@med.wayne.edu.
The Barbara Ann Karmanos Cancer Institute · USChildren's Hospital of Michigan · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
Regulation of Factor VIII SecretionR01HL052173 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 1995 to 2014
$6.5M
Role of the Unfolded Protein Response in Beta CellR37DK042394 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2007 to 2016
$4.9M
Regulation of ER stress-induced cell deathR01DK088227 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2010 to 2014
$3.1M
Genomic screening to identify novel stress-inducing chemotherapies for carcinomaR00DE019678 · NIDCR · WAYNE STATE UNIVERSITY · PI FRIBLEY, ANDREW MICHAEL · 2011 to 2013
$726k
High Throughput Chemical Genomics to Identify Novel Inhibitors of CHOPR03MH084182 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAUFMAN, RANDAL J. · 2008 to 2008
$25k
NCI NIH HHS P30 CA022453NCI NIH HHS P30CA22453NHLBI NIH HHS R01 HL052173NIDCR NIH HHS R00 DE019678NIDDK NIH HHS R01 DK088227NIDDK NIH HHS R37 DK042394NIMH NIH HHS R03 MH084182NIMH NIH HHS R03 MH089787
6 · The paper itself

Abstract

Mortality and morbidity associated with oral squamous cell carcinoma (OSCC) remain unacceptably high with disfiguring treatment options and a death rate of 1 per hour in the United States. The approval of cituximab for advanced OSCC has been the only new treatment for these patients since the 1970s, although it has not significantly increased overall survival. To address the paucity of effective new therapies, we undertook a high-throughput screen to discover small molecules and natural products that could induce endoplasmic reticulum (ER) stress and enforce a terminal unfolded protein response (UPR) in OSCC. The terpenoid cantharidin (CNT), previously used to treat various malignancies in culture-specific medical practices for over 2,000 y, emerged as a hit. CNT and its analog, cantharidic acid, potently induced protein and gene expression profiles consistent with the activation of ER stress, the UPR, and apoptosis in OSCC cells. Murine embryonic fibroblasts null for the UPR-associated transcription factors Atf4 or Chop were significantly protected from CNT, implicating a key role for the UPR in the death response. These data validate that our high-throughput screen can identify novel modulators of UPR signaling and that such compounds might provide a new therapeutic approach to treating patients with OSCC.

Indexed as

Activating Transcription Factor 4AnimalsAntineoplastic AgentsApoptosisArylamine N-AcetyltransferaseBridged Bicyclo Compounds, HeterocyclicCantharidinCarcinoma, Squamous CellCell DeathCell LineCell Line, TumorCell ProliferationCHO CellsCricetinaeCricetulusEndoplasmic Reticulum StressActivating Transcription Factor 4Antineoplastic AgentsArylamine N-AcetyltransferaseAtf4 protein, mouseBridged Bicyclo Compounds, HeterocyclicCantharidinDdit3 protein, mousenorcantharidinRNA, Small InterferingTranscription Factor CHOPATF4cantharidechemotherapyCHOPnatural productsUPR

Identifiers

PMID25425581
PMCPMC4300301
OpenAlexW1976211959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.